PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancers.
PTPN23 依赖的 PI3KC2α 激活是 BRAF 突变癌症的治疗弱点
期刊:Journal of Experimental Medicine
影响因子:10.6
doi:10.1084/jem.20241147
He Ying, Li Wei, Zhang Meiling, Wang Hui, Lin Peilu, Yu Ying, Huang Bin, Hao Meng, He Jianuo, Kong Weiyao, Luo Dan, Xu Tengteng, Wang Jiaqi, Huang Ying, Zhao Qinwen, Liu Ying, Zhang Jie, Nian Yong, Zhang Lei, Zhu Bo, Yin Chengqian
